Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03556228 |
|---|---|
| Brief Title: | Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma |
| First Submitted : | April 29, 2018 |
| First Submitted that Met QC Criteria : | June 1, 2018 |
| First Posted : | June 14, 2018 |
| Last Update Submitted that Met QC Criteria : | July 20, 2022 |
| Last Update Posted : | July 25, 2022 |